Search Protocols under revision. Back New search Go to resultsDiseaseMain groupPediatric Oncology and HematologyProtocol groupBrain Tumors (ped.)DiseaseNeuroblastomaSubgroupICD10C47.-MeSHNeuroblastomaSequenceChemotherapyChemo-substanceCisplatinEtoposideVindesineChemo-substanceCisplatinEtoposideVindesineChemo-substanceCisplatinEtoposideVindesineChemo-substanceCisplatinEtoposideVindesineNo. Substances3 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%Potassium chlorideSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%Potassium chlorideSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%Potassium chlorideSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%Potassium chlorideNo. Substances10Protocol classificationTherapy classificationStudy protocol, currentIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorCaron HNDiseaseNeuroblastom, Kinder unter 1 Jahr oder unter 10 kgOriginDCOG NBL 2009Protocols in Revision 1 protocol foundProtocols under revision.PAED Cisplatin 1.3 / Etoposide 4.2 / Vindesin 0.1, Neuroblastoma, N5 (PID2876 V1.0)
